Company CVAbout Vasundhara Rasayans Ltd 
Vasundhara Rasayans Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Vasundhara Rasayans Limited was incorporated in March, 1987. The Company is the leading manufacturer and exporter of Antacids therapeutic category of Active Pharmaceutical Ingredients with annual capacity of about 1500 MT of powder or its equivalent products. It started its operation in year 1990 with an Antacid API facility offering product in paste, powder and micronised grade of powder.
Company Coordinates
Company Details
Shed No 42 Phase II IDA, Mallapur Hyderabad Telangana : 500076
Registrar Details
Cil Securities Ltd , 214 Raghava Ratna Towers , Chirag Ali Lane, Abidas, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
No Details Available.
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
P & J Cretechem Private Limited (61.98%)
Highest Public shareholder
Garg Leasing And Finance Private Limited (3.55%)
Individual Investors Holdings
30.19%
Board of Directors
Management
Designation
Remuneration
Sunil Jain Kumar.
Executive Director / Whole Tim
12.0 lacs
Sanjoy Kumar Jain
E D & Wholetime Director
16.0 lacs
Rajesh Pokerna
Executive Director & MD
26.0 lacs
Seema Jain
E D & Wholetime Director
10.0 lacs
Pradeep Kumar Jain
Independent Non Exe. Director
15.0 k
Pravichandra Majumdar Popatlal
Independent Non Exe. Director
15.0 k
Rajiv Kakodkar
Independent Non Exe. Director
15.0 k
Manish Jain
Independent Director
0
Ashish Kedia
Independent Director
0
Manish Kumar Jain
Whole-time Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Aluminum Hydroxide Gel/Plate
16.95
100.00%
Aluminum Hydroxide Gel/Plate
Stock DNARevenue and Profits:
Net Sales:
9 Cr
(Quarterly Results - Sep 2025)
Net Profit:
2 Cr
Pharmaceuticals & Biotechnology
INR 61 Cr (Micro Cap)
14.00
40
1.05%
-0.04
12.74%
1.71
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
